MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2017 International Congress

    A case of Dementia with Lewy Bodies Co-Occuring with Multiple Sclerosis

    A. Hannoun, E. DeGrush, K. Smith, T. Kao, A. Deb (Worcester, MA, USA)

    Objective: To describe a unique case of Dementia with Lewy bodies (DLB) co-occurrence with Multiple Sclerosis (MS) Background: Various movement disorders have been described in…
  • 2016 International Congress

    Spectral analysis of rapid eye movement (REM) sleep as a potential marker of neurodegenerative disease in REM sleep behavior disorder

    J. Rodrigues Brazète, J.F. Gagnon, R.B. Postuma, P.A. Bourgouin, D. Petit, J. Montplaisir (Montreal, QC, Canada)

    Objective: To investigate whether spectral analysis at baseline in rapid eye movement (REM) sleep can differentiate patients with REM sleep behavior disorder (RBD) who will…
  • 2016 International Congress

    Effects of zonisamide on dementia with Lewy bodies (DLB): A post-hoc analysis of phase 2 study for parkinsonism in DLB patients

    M. Murata, M. Nakamura, H. Maruyama (Tokyo, Japan)

    Objective: To clarify the effects of zonisamide (ZNS) on the core symptoms of dementia with Lewy bodies (DLB), we performed a post-hoc analysis using data…
  • 2016 International Congress

    Presenting symptoms and cognitive profile in Lewy body dementia: A series of cases

    B. Minafra, G.M.D. Toscano, M. Picascia, R. Zangaglia, N.G. Pozzi, M. Terzaghi, R. Manni, E. Sinforiani, C. Pacchetti (Pavia, Italy)

    Objective: The study aim is to outline the Lewy body dementia (DLB) phenotypes as presenting symptoms and its correlation with cognitive profiles and clinical evolution…
  • 2016 International Congress

    Heart rate variability to differentiate dementia with Lewy bodies from Alzheimer’s disease in patients with mild cognitive impairment

    J. Yoon, S.M. Lee, J.M. Hong (Suwon, Korea)

    Objective: We aimed to determine whether heart rate variability (HRV) can aid in the differentiation of DLB from AD at the MCI stage. Background: Mild…
  • 2016 International Congress

    MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study

    R. Biundo, L. Weis, S. Bostantjopoulou, E. Stefanova, C. Falup-Pecurariu, M.G. Kramberger, G. Geurtsen, A. Antonini, D. Weintraub, D. Aarsland (Venice, Italy)

    Objective: The aims of this study were to investigate which scale is best suited to assess cognition and more sensitive to cognitive decline over time…
  • 2016 International Congress

    Modeling dementia with Lewy bodies using patient-derived neurons

    D.H. Adamowicz, J. Mertens, D.P. Salmon, D.R. Galasko, S. Roy, F.H. Gage (La Jolla, CA, USA)

    Objective: To model Dementia with Lewy bodies (DLB) using neurons derived from patients clinically diagnosed with the disease. Background: A major challenge in neurodegenerative disease…
  • 2016 International Congress

    Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis

    G. Rizzo, S. Arcuti, M. Copetti, M. Alessandria, R. Savica, A. Fontana, R. Liguori, G. Logroscino (Bologna, Italy)

    Objective: To perform a systematic review of the studies on diagnostic accuracy in dementia with Lewy bodies (DLB) and to meta-analyse sensitivity, specificity and accuracy…
  • 2016 International Congress

    Synaptic biomarkers for cognitive decline in Lewy body dementias and Alzheimer’s disease. A mass spectrometry approach

    E. Bereczki, R.M.M. Branca, P.T. Francis, J.H. Baek, J. Lehtio, D. Aarsland (Huddinge, Sweden)

    Objective: The aim of our study is to understand the role of synaptic dysfunction in cognitive decline by comparing the whole proteome of Parkinson's disease…
  • 2016 International Congress

    High frequency of mutations in the glucocerebrosidase (GBA) gene among Ashkenazi Jews with dementia with Lewy bodies

    T. Shiner, A. Mirelman, M. Gana Weisz, A. Bar-Shira, E. Ash, R. Cialic, T. Gurevich, N. Bregman, A. Orr-Urtreger, N. Giladi (Tel Aviv, Israel)

    Objective: The objective of this study was to characterize, clinically and genetically, anAshkenazi Jewish cohort of patients diagnosed with DLB, looking for the association with…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley